PRONOVA BIOPHARMA DANMARK A/S: Financial statements 2013
CVR: 28291736
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
PRONOVA BIOPHARMA DANMARK A/S (CVR 28291736) has filed annual accounts for 2013. In 2013, the company reported revenue of DKK 419,116,611 and a net result of DKK -58,117,455. The profit margin was -13.9%. Equity in the 2013 report amounted to DKK 933,700,494. The solvency ratio was 75.3%. The company had 102 employees in the financial year.
- Revenue
- DKK 419,116,611
- Gross Profit
- DKK 360,391,514
- Profit/Loss
- DKK -58,117,455
- Equity
- DKK 933,700,494
- Total Assets
- DKK 1,240,264,162
- Employees
- 102
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
As of June 26, 2013, EY Godkendt Revisionspartnerselskab has been appointed auditor of PRONOVA BIOPHARMA DANMARK A/S.
As of June 26, 2013, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of PRONOVA BIOPHARMA DANMARK A/S.
As of June 26, 2013, Charlotte Berg-Svendsen has joined the board of directors of PRONOVA BIOPHARMA DANMARK A/S.
As of June 26, 2013, Synne Hermansen Røine has left the board of directors of PRONOVA BIOPHARMA DANMARK A/S.
As of June 26, 2013, Ralf Fink is registered as chairman of PRONOVA BIOPHARMA DANMARK A/S.
As of June 26, 2013, Morten Jurs has stepped down as chairman of PRONOVA BIOPHARMA DANMARK A/S.
PRONOVA BIOPHARMA DANMARK A/S has published its annual report for 2012.
About PRONOVA BIOPHARMA DANMARK A/S
PRONOVA BIOPHARMA DANMARK A/S was a Danish company of the type Aktieselskab based in Kalundborg, founded in 2004. The company has been dissolved on 28 January 2014. The company was registered under the industry Fremstilling af olier og fedtstoffer. The company was previously named PRONOVA BIOCARE DENMARK A/S and SCSK 3470 A/S. The company has 100 employees (2013). In 2013, the company reported revenue of DKK 419,116,611 and a net result of DKK -58,117,455. Equity in the 2013 report amounted to DKK 933,700,494.
